1 study found for:    21047225 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies
Conditions: Lymphoma, Non-Hodgkin;   Disease, Hodgkin;   Lymphoma, Large-Cell, Anaplastic
Intervention: Drug: SGN-35

Indicates status has not been verified in more than two years